12MAY

ECDC counts 11 Andes cases, three more than WHO

3 min read

16:29UTC

ECDC published a 12 May surveillance update recording 11 MV Hondius cases across six countries, three higher than the 8 reported in WHO's revised DON 600 on 9 May, with a three-day reporting lag the most likely explanation for the discrepancy.

← Back to B3.13 gets better at humans as testing ends Jump to analysis ↓

ScienceDeveloping

Key takeaway

ECDC's 12 May tally of 11 cases exceeds WHO's 9 May figure of 8, a three-day reporting lag.

ECDC (European Centre for Disease Prevention and Control, the EU's infectious disease surveillance agency based in Stockholm) published updated Andes hantavirus surveillance data on 12 May, recording 11 cases (9 confirmed, 2 probable) and 3 deaths across 6 countries linked to the MV Hondius cluster . ¹ The figure is three cases higher than the 8 reported in WHO DON 600, revised on 9 May. Both agencies draw on national contact-tracing reports from the same six affected countries. The gap reflects a three-day reporting lag, with WHO's figure representing the state as of 9 May and ECDC's representing Tuesday 12 May. Neither agency has publicly attributed the discrepancy to differing case-definition thresholds, though that remains a secondary possibility.

ECDC had published a Technical Assessment Brief on 6 May and issued passenger management guidance on 9 May, operationalising the WHO risk upgrade within the EU/EEA context. PAHO had warned five months before the voyage that hantavirus incidence across the Southern Cone was rising with higher case fatality than baseline ; ECDC's rapid technical assessment and the WHO/ECDC count divergence together illustrate the multi-agency coordination demand that Andes events impose on health systems accustomed to treating hantaviruses as single-country, rodent-only transmission events.

The ECDC CDTR (Communicable Disease Threats Report) Week 20 edition, expected 16-17 May, will likely carry the next formal case-count reconciliation and may formally confirm or exclude the Tristan da Cunha suspected case. Until that edition, the published count will continue to diverge between WHO and ECDC, with ECDC's figures the more recent.

Deep Analysis

In plain English

Two international health organisations are tracking the same outbreak. **ECDC** (the European Centre for Disease Prevention and Control) is the EU's disease surveillance body, based in Stockholm. **WHO** (the World Health Organisation) tracks outbreaks globally, drawing on the same national reports from the six affected countries. On 12 May, ECDC counted 11 cases. Three days earlier, WHO counted eight. WHO's figure comes from 9 May; ECDC's from 12 May, three days later, during which period national laboratories in the Netherlands, Germany, and South Africa continued processing samples. A second possibility: ECDC and national health authorities in the Netherlands and Germany apply a slightly broader case definition than WHO's index-country standard, producing a persistent one-to-two-case gap even when the timings align. This kind of gap is common in fast-moving outbreaks. It is not a sign that either organisation is wrong; it is mostly a sign that disease reporting across six countries in multiple languages takes time to standardise.

Source Landscape

This story draws on neutral-leaning sources

Primary parallel: The 2020-2022 COVID-19 case count divergence between ECDC and WHO for EU member states showed the same pipeline structure at scale: ECDC numbers consistently led WHO numbers for European cases by 24-72 hours. No clinical or policy consequence followed from the lag in routine surveillance, but during the October 2020 autumn wave, ECDC's higher figures generated public alarm in EU member states one to two days before WHO confirmed equivalent numbers.

Counter-parallel: The 2009 H1N1 pandemic demonstrated that WHO and regional organisations can rapidly converge on shared case definitions when the political pressure to do so is high enough. A MODERATE-tier outbreak with a 38% CFR may generate that convergence pressure within the week, reducing the divergence to a historical artefact.

Consensus view: ECDC Director Andrea Ammon has publicly acknowledged that ECDC and WHO operate parallel surveillance pipelines with different case-definition reference documents: ECDC applies its own Communicable Disease Threats Report (CDTR) case definition, while WHO DONs apply the case definition in the original notification from the index country's national authority.

For a cluster spanning six countries, neither pipeline has a single authoritative input; both aggregate national reports that themselves apply varying national case definitions, and a 3-case gap on day three of a multi-country cluster falls within the typical inter-agency lag range.

Counter-view: Suerie Moon (Geneva Graduate Institute, global health governance scholar) has argued that the repeated pattern of ECDC-WHO case count divergence, visible in mpox (2022) and COVID-19 (2020-2022), reflects a governance structural problem: the EU has effectively created a parallel outbreak notification system for the 27 EU/EEA member states that competes with rather than feeds WHO.

For a non-EU affected country, such as the UK or Switzerland reporting MV Hondius cases, the feed to WHO is direct; for Netherlands and Germany, the national report goes to ECDC and then to WHO with an additional transit lag.

Key tension: Whether the ECDC-WHO divergence represents a workable institutional division of labour or an accumulating governance fragmentation that will produce materially different public risk communications during a fast-moving outbreak.

Sources:ECDC·ECDC

Mentions:World Health Organization →Andes virus →MV Hondius →Geneva →Southern Cone →Germany →PAHO →South Africa →Tristan da Cunha →DON 600 →Suerie Moon →Switzerland →Netherlands →ECDC →CDTR →

First Reported In

Update #2 · B3.13 gets better at humans as testing ends

ECDC· 12 May 2026

Read original →

Causes and effects

Caused by

Andes hantavirus confirmed in Swiss returnee

MV Hondius cluster is the event tracked in the ECDC 12 May surveillance update.

Occurred 7 May 2026

Read story →

This Event

ECDC counts 11 Andes cases, three more than WHO

A three-case gap between WHO and ECDC at equivalent points in the same outbreak reflects different national reporting speeds rather than genuine scientific disagreement, but it is the kind of coordination gap that slows cross-border clinical decision-making in the first weeks of a novel cluster.

Different Perspectives

NTI Bio and Resolve to Save Lives

NTI Bio and Resolve to Save Lives have consistently argued that the WHA Pandemic Agreement's Pathogen Access and Benefit-Sharing annex is its operational core. A failed PABS outcome at WHA79 in late May leaves the treaty without a legal mechanism for rapid vaccine sharing.

UK Health Security Agency

UKHSA confirmed on 6 May that British nationals are among MV Hondius cases and placed the UK in the European secondary-monitoring picture. UKHSA's active monitoring obligation covers Andes-specific person-to-person transmission risk, not generic hantavirus protocol.

Africa CDC and ASLM

Africa CDC and ASLM launched ARILAC in Addis Ababa on 6 May alongside the EU, targeting AMR laboratory capacity in 8 AU states where 1.3% of assessed labs currently conduct routine resistance testing.

CEPI (Coalition for Epidemic Preparedness Innovations)

CEPI announced on 22 April that Moderna's mRNA H5N1 vaccine candidate entered Phase 3 trial. CEPI's position is that pre-pandemic efficacy data collected now is the only credible path to a 100 Days Mission authorisation if H5N1 achieves sustained human-to-human spread.

World Health Organization

WHO Disease Outbreak News 599, published 2 May, assessed the MV Hondius cluster as low global risk under standard hantavirus protocol. The Swiss Andes confirmation, released after DON 599 closed, makes that rodent-only framing outdated before the bulletin was indexed.

Africa CDC

Africa CDC lifted the mpox PHECS on 22 January 2026 after clade I CFR dropped from 2.6% to 0.6% and confirmed cases fell roughly 60% from peak. Clade Ib community transmission continues in 11 countries and WHO standing recommendations remain in force through 20 August 2026, so the lift tracks improved trends, not containment.